Table 4.
Secondary outcomes | Pregnant cases (n=38) |
Nonpregnant controls (n=94) |
Adjusted P value | Ratio of means (95% CI) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
N | Mean±SD | Median (IQR) | Range | N | Mean±SD | Median (IQR) | Range | |||
Length of stay | ||||||||||
Hospital length of stay (d) | 38 | 8.7±8.1 | 5.5 (4–10) | 2–42 | 94 | 7.1±8.2 | 5 (3–9) | 1–53 | .08 | 0.8 (0.6–1.0)b |
ICU length of stay (d)a | 15 | 6.4±6.9 | 4 (1–9) | 0–26 | 16 | 9.3±11.8 | 5.5 (2–12) | 0–45 | –– | –– |
n/N (%) | n/N (%) | Adjusted OR (95% CI) | ||
---|---|---|---|---|
ICU admission | 15/38 (39.5) | 16/94 (17.0) | <.01 | 5.2 (1.5–17.5) |
Discharge disposition | .77 | |||
Home without O2 requirement | 35/38 (92.1) | 77/94 (81.9) | Ref | |
SNF or LTAC or home with O2 or other requirements | 3/38 (7.9) | 14/94 (14.9) | 0.8 (0.3–2.8) | |
Morbidity during admission | ||||
Any morbidity | 12/38 (31.6) | 20/94 (21.3) | .57 | 1.4 (0.4–5.0) |
Sepsis | 2/38 (5.3) | 7/94 (7.4) | ||
Cardiac arrest | 1/38 (2.6) | 3/94 (3.2) | ||
ARDS | 6/38 (15.8) | 7/94 (7.4) | ||
Ventilation | 10/38 (26.3) | 10/94 (10.6) | ||
Tracheostomy | 3/38 (7.9) | 1/94 (1.1) | ||
Blood product transfusion | 2/38 (5.3) | 1/94 (1.1) | ||
AKI | 0/38 (0.0) | 3/94 (3.2) | ||
Shock | 2/38 (5.3) | 4/94 (4.3) | ||
Other morbidity | 0/38 (0.0) | 3/94 (3.2) |
AKI, acute kidney injury; ARDS, acute respiratory distress syndrome; CI, confidence interval; ICU, intensive care unit; IQR, interquartile range; LTAC, long-term acute care; OR, odds ratio; Ref, referend; SD, standard deviation; SNF, skilled nursing facility.
DeBolt et al. Severe and critical COVID-19 in pregnant vs nonpregnant controls. Am J Obstet Gynecol 2021.
ICU length of stay is only calculated for those 31 patients who were admitted to the ICU (15 pregnant cases and 16 nonpregnant controls)
Hospital length of stay was log transformed and modeled using linear regression. The beta coefficient for the cases was exponentiated to estimate the ratio of the geometric means.